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The purpose of the present study was to examine protein kinase C (PKC) isotype expression in T lymphoblasts derived from peripheral blood 
and the T leukaemic ell Jurkat. Using antisera reactive with PKC a, pi, and /?, and y, it was observed that T cells expressed two PKC isotypes, 
PKC a and /I,. No PKC y was detected in T lymphocytes. In lymphoblasts, high levels of PKC B compared to PKC a were found whereas Jurkat 
cells expressed high levels of a compared to PKC /3. Differences in the calcium sensitivity of phorbol ester-induced phosphorylation were observed 
in Jurkat and T lymphoblasts which correlated with the relative levels of PKC a and fi isotypes expressed by the cells. 
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1. INTRODUCTION 
Activation of T lymphocytes is associated with PKC- 
regulated phosphorylation of a number of T cell pro- 
teins including the CD4, CDS and CD45 molecules, the 
y subunit of the CD3 antigen and two cytosolic proteins 
of A4, 80 000 and 19 000 [l-6]. PKC also regulates the 
expression of cellular receptors for IL2 and the produc- 
tion of lymphokines such as IL2, and thus has an im- 
portant role in the intracellular signalling pathways that 
control T cell activation [7,8]. 
The purification and gene cloning of PKC has led to 
identification of at least seven isotypes of PKC [9-121 
that have different enzymological characteristics 
[ 14,151 and may control distinct cellular responses [ 131. 
Most cells express more than one PKC isotype [B-17] 
and it appears that T lymphocytes express a minimum 
of two isotypes [l&20], type II or PKC ,B and type III 
or PKC a [ 18-191. Recent studies have suggested that T 
lymphocytes may be heterogeneous in the ratio of PKC 
isotype expression [13,19]. In this respect, we have 
observed differences in the calcium sensitivity of PKC 
in two T cell populations used commonly in signal 
transduction studies; peripheral blood-derived T lym- 
phoblasts and the T-leukaemic cell Jurkat (56) [21]. 
Since different PKC isotypes exhibit differential 
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calcium sensitivity in vitro [13], the object of the present 
study was to explore whether differences in PKC 
isotype expression correlated with differences in PKC 
regulation in Jurkat cells and peripheral blood lym- 
phocytes. 
2. MATERIALS AND METHODS 
2.1. Materials and cells 
Reduced streptolysin 0 was obtained from Wellcome diagnostics 
(Dartford, Kent, England). [y-‘*P]ATP (370 MBq/ml) and myo- 
[‘HJinositol (3.05 TBq/mmol) were obtained from Amersham Inter- 
national (Amersham, England). All nucleotides were from Boehr- 
inger Mannheim (Sussex, England). PDBu and other biochemicals 
were obtained from Sigma (Dorset, England). PKC isotope-specific 
antisera were raised in rabbits against peptides unique to the different 
PKC isotypes. The characterisation and specificity of these antisera 
have been described previously [ 141. The 56 subclone of Jurkat cells 
and human peripheral blood-derived T lymphoblasts were prepared 
and maintained as described previously [2]. The purity of the T lym- 
phoblast populations used was ~99% as judged by flow cyto- 
fluorometric analysis with a CD3 antibody [2]. 
2.2 Cell permeabilisation, phosphorylation and immunoprecipita- 
tion 
T cells were washed twice and resuspended at 5 x IO’ cells/ml in 
permeabilisation medium containing 0.4 IU/ml streptolysin 0, 120 
mM KCI, 30 mM NaCl, 10 mM Hepes (pH 7.2), 10 mM EGTA and 
10 mM MgClr. The concentrations of CaCla required to give free 
calcium in the range of nominal zero to 1 PM at 37°C and pH 7.2 were 
predicted by the computer program CHELATE using appropriate 
dissociation constants for Ca2+, Mg2+ and H+ [21]. Phosphory- 
lation of proteins in permeabilised cells was carried out by 
permeabilising 2.5 x 10’ cells in the presence of 1OOrM [y-“P]ATP 
(1 &i/pmol) and the specified stimulant. Following incubation at 
37°C for 10 min, cells were pelleted at 8000 x g for 5 s and lysed in 
a buffer containing 150 mM NaCl, 10 M Tris/HCl (pH 7.4), 1% 
NP40,l mM EDTA, 10 mM Na pyrophosphate and 50 mM NaF. The 
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Fig.1. Ca*+ and PDBu stimulation of CD3 y chain phosphorylation 
in T lymphoblasts and 56 cells. Permeabilised cells were incubated for 
5 min in the presence of 500 nM Ca*+ , and [y-“P]ATP either with 
(+) or without (-) 20 ng/ml PDBu. The data show SDS-PAGE 
analyses of CD3 antigen immunoprecipitates. 
CD3 antigen was immunoprecipitated using the CD3 antibody 
UCHTl [2,22]. CD3 antigens were separated by 12% (w/v) SDS- 
PAGE under reducing conditions. Gel autoradiographs were scanned 
using an LKB Ultroscan XL densitometer. 
2.3. Western blotting 
Cells were lysed (2 x lO’/ml) in SDS sample buffer (1% SDS, 10% 
(v/v) glycerol, 100 mM Tris-HC1 buffer, pH 6.8,0.2% Bromophenol 
blue, 0.1 M dithiothreitol) and analysed by SDS-PAGE. Proteins 
were electrophoretically transferred at 4°C from SDS gels to 
nitrocellulose filters and immunoblotted as described [4] using PKC 
isotype-specific antisera diluted lOOO-fold with or without competing 
peptide. Bound antibody was visualised using ‘*‘I-protein A (Amer- 
sham International) followed by autoradiography. 
3. RESULTS 
3.1. Different signalling requirements for CD3 
antigen phosphorylation in Jd and peripheral 
blood-derived T cells 
We have recently described a permabilished cell 
system that uses Ca2 + /EGTA buffers to control 
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cytosolic [Ca’ ‘1 levels, thus allowing the [Ca2 + ] 
dependency of PKC activation to be monitored [21]. In 
T cells, the y subunit of the CD3 antigen is phospho- 
rylated by PKC-mediated events [2,21,23]. The effect 
of [Ca2 ‘1 on PKC-mediated CD3 y-chain phospho- 
rylation in 56 cells and T lymphoblasts is shown in figs 
1 and 2. In T lymphoblasts, 500 nM Ca2+ induced a 
weak phosphorylation of the A4, 26000 CD3 y chain 
which was enhanced j-fold by PDBu (fig.1). In con- 
trast, in 56 cells, 500 nM Ca2+ alone induced strong 
CD3 antigen phosphorylation which was enhanced only 
2-fold by PDBu (fig.1). A more detailed analysis of the 
[Ca2 + ] dependency of CD3 y chain phosphorylation in 
T lymphoblasts and 56 cells is shown in fig.2. In T lym- 
phoblasts, PDBu-induced CD3 y-subunit phosphoryla- 
tion is relatively insensitive to [Ca2 ‘1 and 60% maximal 
CD3 y-chain phosphorylation was induced by PDBu at 
a nominal zero [Ca2+] (fig.2A). Maximal PDBu- 
induced phosphorylation occurred at 500 nM and 
declined at 1 /cM Ca2 + . In 56 cells, the effect of PDBu 
was markedly sensitive to [Ca2’] with only a weak 
(16% of maximal) effect at nominal zero Ca2 + and a 
maximum synergy at 150 nM Ca2+ (fig.2B). Ca2+ 
alone induced significant CD3 antigen phosphorylation 
which was readily detectable at 150 nM Ca2 + and 500 
nM Ca2 + (figs 1 and 2). 
3.2. PKC isotype expression in Jd and peripheral 
blood-derived T cells 
To examine PKC expression in T lymphocytes, PKC 
isotype-specific antiserum were used in Western blot 
analyses of T cell lysates. As a positive control for each 
antiserum, PKC purified from bovine brain containing 
LY, 8 and y isotypes was analysed in parallel. The reac- 
tivity of the PKC a, 81, /?2 and y antisera with brain 
PKC is shown in fig.3A. However, no PKC y was 
detected in 56 or normal T lymphoblasts (fig.3B). The 
reactivity of PKC cy, ,81 and fix antisera with 56 and T 
lymphoblast PKC is shown in fig.3B. Both T cell 
populations examined expressed PKC cy and /31 iso- 
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Fig.2. Ca* + -dependent e of CD3 y-chain phosphorylation in permabilised 56 and T lymphoblasts. Permeabilised cells were incubated for 5 min 
with the indicated concentration of calcium either with (0) or without (0) 20 ng/ml PDBu. The CD3 antigen was immunoprecipitated, analysed 
by SDS-PAGE and “P-incorporation quantified by densitometric scans of gel autoradiographs. The data show the 9’0 maximum CD3 y-chain 
phosphorylation in T lymphoblasts (A) and 56 cells (B). 
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Fig.3. PKC isotype expression in brain, T lymphoblasts and 56 cells. Data show Western blot analyses of PKC 7, cy, #?r and& isotypes. (A) Bovine 
brain; (B) T lymphoblasts and 56 cells (lanes 1 and 2 respectively). 
Fig.4. Data show 3 experiments in which relative levels (arbitrary 
units) of PKC cx (columns 1,2) and PKC ,iYr (columns 3,4) in Jurkat 
cells (8) and T lymphoblasts (m) were quantitated by densitometric 
scans of PKC Western blots. 
types. It has been described previously that the T 
leukaemic HPBALL cell expresses a high ratio of PKC 
CY compared to PKC ,8 [ 191. Western blot analyses of 56 
cells (fig.3) demonstrate that they also express high 
levels of PKC cy compared to PKC ,8. Conversely, T 
lymphoblasts express higher levels of PKC ,8 than J6 
cells. 
Quantitation of PKC cy and ,8 levels by densitometric 
analysis of PKC Western blots indicates that Jurkat 
cells express 4-fold higher levels of PKC Q than T lym- 
phoblasts. T lymphoblasts express 2-fold higher levels 
of PKC fi than Jurkat cells (fig.4). Accordingly, the 
ratio of PKC ,8 to PKC cz is higher in T lymphoblasts, 
whereas the ratio of PKC CY to ,8 is higher in Jurkat cells. 
4. DISCUSSION 
The present study demonstrates that peripheral blood- 
derived T lymphocytes and 56 cells express PKC cy and 
,O but not A isotypes. 56 cells express high levels of PKC 
cr but low levels of the ,@ isotype, whereas peripheral 
blood-derived T lymphoblasts contain high levels of 
PKC p but relatively low levels of the a isotype, High 
levels of PKC cy have also been observed in the T 
leukaemic HPBALL cells. 56 and HPBALL cells are 
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leukaemic cells and it is possible that a high ratio of 
PKC CY compared to PKC ,f3 is a characteristic of 
transformed T lymphocytes. 56 and HPBALL cells are 
also representative of an earlier, thymic stage of T cell 
ontogeny than peripheral blood-derived T lympho- 
blasts. The data suggest herefore that PKC isotype ex- 
pression may be regulated during T lymphocyte dif- 
ferentiation. 
56 cells and T lymphoblasts differ in the [Ca2’] sen- 
sitivity of the phosphorylation of CD3 y chains in 
permeabilised cells. One major difference is that at a 
nominal zero [Ca2 +I, PDBu induces 60% maximal 
CD3 antigen phosphorylation in T lymphoblasts but 
only 16% maximal CD3 antigen phosphorylation in 56 
cells. PKC CY and ,f3 isotypes are differentially sensitive 
to Ca2 + [ 131 since, using histone as a substrate, PKC CY 
and p can be stimulated to 18% and 65% of maximal 
activity, respectively, in the absence of Ca2 + . The 
calcium sensitivity of PKC isotypes may be in part a 
substrate-based phenomenon [141. Nevertheless, the in 
vitro calcium sensitivity of the PKC a and ,8 isotypes 
and their relative levels of expression in 56 cells and T 
lymphoblasts, could explain differences in the [Ca2+] 
sensitivity of PDBu-induced CD3 antigen phosphoryla- 
tion in permeabilised T cells. However, it must be con- 
sidered also that T cells might express other PKC 
isotypes that vary in their calcium sensitivity. In this 
regard the expression of PKC 6 and E in T lymphocytes 
has not been examined. 
In the absence of phorbol esters, Ca2 + induces CD3 
antigen phosphorylation in 56 cells but not T lym- 
phoblasts. It is not known whether this phenomenon is 
related to the pattern of PKC isotype expression in the 
cells. However, we have observed that inositol phos- 
pholipid turnover is stimulated by low levels of calcium 
(50 nM) in permeabilised 56 cells but not in T lym- 
phoblasts (unpublished observation). This suggests that 
endogenous levels of diacylglycerol will be higher in 
permeabilised 56 cells compared to T lymphoblasts 
which would explain the higher basal PKC activation in 
the cells. 
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